Wellbutrin is a brand of bupropion, a norepinephrine–dopamine reuptake inhibitor (NDRI) used for major depressive disorder, seasonal affective disorder, and smoking cessation (as Zyban). It stands out for low sexual side effect risk and potential energy and focus benefits. Available as immediate-release, SR, and XL tablets, it must be used exactly as prescribed to minimize seizure risk. This guide covers uses, dosing, safety, side effects, interactions, and what to do about missed or overdosed doses. While online ads may promise shortcuts, Wellbutrin is prescription-only in the U.S.—seek clinician-guided, lawful care to determine whether it’s appropriate for you now and safe.
Wellbutrin is an antidepressant in the norepinephrine–dopamine reuptake inhibitor (NDRI) class. Clinicians prescribe it primarily for major depressive disorder (MDD) and seasonal affective disorder (SAD). Unlike selective serotonin reuptake inhibitors (SSRIs), bupropion has minimal direct serotonergic activity, which often translates to a lower risk of sexual dysfunction and weight gain. Some patients also report improved energy, motivation, and concentration as their mood improves, making it a practical option when fatigue or cognitive slowing accompany depression.
Beyond its depression indications, bupropion is used for smoking cessation under the brand Zyban. By modulating dopaminergic and noradrenergic pathways implicated in reward and withdrawal, it can help reduce nicotine cravings and attenuate withdrawal symptoms. Clinicians may also consider bupropion in patients who have not tolerated or responded to other antidepressants, or when comorbid conditions—such as weight concerns or sexual side effects—make alternatives less appealing.
Off-label, some providers use bupropion as adjunctive therapy for attention-related symptoms or SSRI-associated sexual dysfunction; these uses require careful clinical judgment and are not appropriate for everyone. As with all antidepressants, the benefits of Wellbutrin emerge gradually over weeks, and the full therapeutic effect may require dose optimization and consistent daily use under medical supervision.
Wellbutrin is available as immediate-release (IR), sustained-release (SR), and extended-release (XL) tablets. Because seizure risk increases with higher doses and rapid titration, prescribers typically start low and adjust gradually. For MDD, common starting doses include 150 mg once daily for XL; for SR, 150 mg once daily for several days, then 150 mg twice daily; and for IR, smaller split doses. The maximum recommended total daily dose for most adults is 450 mg, with specific limits per formulation. Dose selection depends on the indication, formulation, patient factors, and tolerability.
For seasonal affective disorder, Wellbutrin XL is often initiated before the onset of fall/winter symptoms and tapered in spring, following a schedule determined by a clinician. For smoking cessation (Zyban), a typical pattern is 150 mg once daily for three days, then 150 mg twice daily, started one to two weeks before the target quit date. Not all patients are candidates for bupropion-based cessation therapy, especially those with seizure risk factors.
Tablets should be swallowed whole; do not crush, split, or chew SR or XL formulations, as doing so can increase adverse effects and seizure risk. Take doses at the same time each day, and for SR/IR, space them as directed to avoid dose clustering. Your prescriber will individualize dosing based on response, side effects, liver or kidney function, age, and concomitant medications. Never change your dose or frequency without medical guidance.
Seizure risk is the most prominent safety consideration with bupropion. Risk rises with higher total daily doses, certain co-administered medications, and specific medical histories. Patients with conditions that lower the seizure threshold—such as eating disorders, abrupt alcohol or benzodiazepine withdrawal, severe head trauma, CNS tumors, or uncontrolled epilepsy—require special caution or alternative treatments. Strict adherence to prescribed dosing and avoiding rapid titration are essential risk-mitigation steps.
All antidepressants carry a boxed warning about increased risk of suicidal thoughts and behaviors in children, adolescents, and young adults, especially early in treatment or after dose changes. Monitor for mood swings, agitation, irritability, or unusual behavior changes, and seek immediate help if concerning symptoms arise. Patients with bipolar disorder may be at risk for manic or hypomanic episodes; a careful history to screen for bipolar spectrum illness is important before starting therapy.
Other precautions include hypertension (bupropion can increase blood pressure), angle-closure glaucoma risk in susceptible individuals, and potential allergic reactions (including rare severe rashes). Alcohol can increase neuropsychiatric side effects and seizure risk; limiting or avoiding alcohol is advised. Pregnancy and lactation considerations require individualized risk–benefit discussions; if you are pregnant, planning to become pregnant, or breastfeeding, consult your clinician to weigh alternatives and monitoring plans.
Do not use bupropion if you have a seizure disorder; a current or past diagnosis of bulimia or anorexia nervosa; known hypersensitivity to bupropion or its components; are using an MAOI or have used one within the past 14 days; or are taking other bupropion-containing products (e.g., Zyban) due to cumulative dosing. It is also contraindicated in patients undergoing abrupt discontinuation of alcohol, benzodiazepines, barbiturates, or antiepileptic drugs. These conditions significantly elevate seizure risk or pose other serious safety concerns.
Common side effects include dry mouth, nausea, insomnia, headache, constipation, dizziness, sweating, tremor, and anxiety or restlessness. Some people experience decreased appetite and modest weight loss, which may be desirable or undesirable depending on individual health goals. Taking the medication earlier in the day can sometimes help with activation or sleep disruption, depending on the formulation and prescriber guidance.
Serious adverse effects are less common but require prompt medical attention. These include seizures (risk is dose- and risk-factor–dependent), significant increases in blood pressure, severe allergic reactions (rash, hives, swelling, difficulty breathing), visual changes suggestive of angle-closure glaucoma, and neuropsychiatric symptoms such as agitation, paranoia, or hallucinations. In patients using nicotine replacement therapy with bupropion for smoking cessation, monitor blood pressure closely due to a higher risk of hypertension.
Sexual side effects are typically lower compared with many SSRIs, which can be an advantage for some patients. However, individual responses vary, and side effects often improve over time or with dose adjustments. If side effects are persistent or troublesome, do not stop Wellbutrin abruptly; contact your clinician to discuss tailored strategies, which may include timing changes, dose modifications, or alternative therapies.
Bupropion is a strong inhibitor of CYP2D6, which can raise blood levels of medications metabolized by this pathway. Examples include certain SSRIs and SNRIs (e.g., paroxetine, duloxetine), tricyclics, antipsychotics (e.g., risperidone), beta-blockers (e.g., metoprolol), and the activation of tamoxifen (which may be reduced when CYP2D6 is inhibited). When combining Wellbutrin with these medications, clinicians may adjust dosing or select alternatives, and they will monitor for enhanced effects or side effects.
Medications that affect CYP2B6 can alter bupropion levels. Inhibitors (e.g., clopidogrel, ticlopidine) may increase bupropion exposure, while inducers (e.g., ritonavir, lopinavir, efavirenz, carbamazepine, phenytoin, phenobarbital) can lower it, potentially reducing efficacy. Always provide a complete medication list, including over-the-counter drugs and supplements, to enable safe, informed prescribing.
Avoid using Wellbutrin with monoamine oxidase inhibitors (MAOIs), and exercise caution with other agents that lower seizure threshold, such as antipsychotics, other antidepressants at high doses, tramadol, theophylline, systemic corticosteroids, and quinolone antibiotics in susceptible patients. Alcohol can increase neuropsychiatric effects and seizure risk. Linezolid or intravenous methylene blue carries MAOI-like risks and warrants special handling. Nicotine replacement therapies may be combined for smoking cessation under medical supervision with blood pressure monitoring.
If you miss a dose, take it as soon as you remember unless it is close to the time of your next dose. If it is near the next scheduled dose, skip the missed dose and resume your regular schedule. Do not double up to make up for a missed dose, as dose stacking increases the risk of adverse effects, including seizures. For SR and IR formulations, maintain the prescribed spacing between doses; for XL, take it once daily as directed.
Bupropion overdose can cause seizures, severe agitation, hallucinations, rapid heartbeat, arrhythmias, nausea and vomiting, drowsiness, or loss of consciousness. Extended-release products may lead to delayed symptom onset, with seizures occurring many hours after ingestion. If an overdose is suspected, call emergency services or poison control immediately. Do not induce vomiting unless instructed by a medical professional. Supportive care, continuous cardiac and neurological monitoring, and management of complications are the mainstays of treatment in a healthcare setting.
Store Wellbutrin at room temperature (typically 15–30°C/59–86°F) in a dry place away from excessive heat, moisture, and direct light. Keep tablets in their original container with the label intact, and out of reach of children and pets. Do not crush or break SR/XL tablets. Dispose of unused or expired medication responsibly—use a drug take-back program when available or follow FDA/DEA guidance for safe disposal. Never share prescription medicines with others.
In the United States, Wellbutrin (bupropion) is a prescription-only medication. Buying Wellbutrin without a prescription is unsafe and may be unlawful. The appropriate pathway involves evaluation by a licensed clinician who can determine whether bupropion is clinically indicated, select the correct formulation (IR, SR, or XL), and monitor for efficacy, side effects, and interactions. This safeguards you against avoidable risks such as seizures, hypertensive reactions, or dangerous drug interactions.
Surgery Center of Pottsville offers a legal, structured, and patient-centered process to access care for conditions like depression, seasonal affective disorder, and smoking cessation. Through compliant in-person or telehealth evaluations with licensed professionals, you can receive an individualized treatment plan and, when appropriate, a valid prescription for Wellbutrin that is filled through trusted pharmacy partners. No medications are supplied without a clinician’s assessment and a legitimate prescription, ensuring safety, transparency, and adherence to U.S. regulations.
Wellbutrin, the brand name for bupropion, is an atypical antidepressant classified as a norepinephrine–dopamine reuptake inhibitor (NDRI). It boosts levels of norepinephrine and dopamine, which can improve energy, motivation, and mood without significant serotonin effects.
Bupropion is approved for major depressive disorder and seasonal affective disorder (SAD). A sustained-release form is also approved as Zyban for smoking cessation. Clinicians may use it off-label for ADHD, antidepressant-induced sexual dysfunction, and certain fatigue syndromes.
Some people notice improved energy, concentration, or motivation within 1–2 weeks, but mood improvement typically builds over 4–6 weeks. Smoking cravings may lessen within the first 1–2 weeks when used for cessation.
Common effects include dry mouth, insomnia, headache, anxiety or jitteriness, nausea, tremor, and increased sweating. Blood pressure can rise in some people. Most effects are mild and improve over time; persistent or severe symptoms should be discussed with a clinician.
Bupropion is more often weight-neutral or associated with mild weight loss compared with many SSRIs and SNRIs. Individual responses vary; maintaining healthy diet and activity is still important.
Unlike many SSRIs, Wellbutrin tends to have fewer sexual side effects and may improve libido and arousal in some people, especially when added to an SSRI causing sexual dysfunction. Individual experiences differ.
Avoid bupropion if you have a seizure disorder, a current or prior diagnosis of bulimia or anorexia nervosa, are on or recently used an MAOI, or have abruptly stopped alcohol, benzodiazepines, or sedatives. Use caution with significant head injury, severe liver disease, or uncontrolled hypertension.
Wellbutrin is not an anti-anxiety medication, and its activating profile can temporarily worsen anxiety or insomnia, especially early on. Some people with depression and low energy feel less anxious as mood improves. For primary anxiety disorders, SSRIs/SNRIs or psychotherapy may be preferred.
IR is immediate-release (usually taken 2–3 times daily), SR is sustained-release (typically twice daily), and XL is extended-release (once daily). All contain bupropion; XL often has smoother blood levels and may reduce insomnia or jitteriness for some patients.
Common depression doses range from 150 mg to 300 mg daily (XL once daily; SR divided twice daily). Some patients may go to 450 mg/day if tolerated and clinically indicated. Dosing is individualized; never crush or split SR/XL tablets, and follow your prescriber’s plan.
Do not combine with MAOIs. Use caution with other drugs that lower seizure threshold (for example, tramadol, some antipsychotics, high-dose stimulants) or that raise bupropion levels (CYP2B6 inhibitors). Bupropion inhibits CYP2D6 and can increase levels of medications like certain SSRIs, SNRIs, beta-blockers, and tamoxifen.
Alcohol can increase the risk of seizures and worsen mood or sleep. Heavy or binge drinking is particularly risky with bupropion. If you drink, discuss safer limits with your clinician; many people choose to avoid alcohol while on therapy.
Take it when you remember unless it’s close to the next dose; if so, skip the missed dose and resume your schedule. Do not double up, and avoid taking late-day doses that may disrupt sleep.
Bupropion has a lower risk of discontinuation symptoms than SSRIs/SNRIs, but abrupt stopping can still cause mood changes, irritability, or sleep issues. It’s best to taper under medical guidance.
Data in pregnancy are mixed; bupropion may be considered if benefits outweigh risks, particularly when other options fail or for smoking cessation in select cases. Small amounts pass into breast milk; infants should be monitored for irritability or poor feeding. Always decide with your obstetric and pediatric clinicians.
Bupropion is sometimes used off-label for ADHD, especially when stimulants aren’t tolerated or when depression and nicotine dependence coexist. Benefits are generally modest compared with stimulants.
As Zyban (bupropion SR), it reduces cravings and withdrawal by modulating dopamine and norepinephrine pathways. It’s often started 1–2 weeks before quit day and combined with behavioral support; nicotine replacement can be used alongside under guidance.
Seek urgent care for seizures, severe allergic reactions (rash, swelling, trouble breathing), mania or unusually elevated mood, severe hypertension, or suicidal thoughts/worsening depression. Report persistent insomnia, anxiety, or palpitations to your prescriber.
Take in the morning (and early afternoon for SR/IR) to reduce insomnia, and avoid late doses. Swallow SR/XL tablets whole and take with food if nausea occurs. Monitor blood pressure, sleep, mood, and any unusual symptoms, and keep regular follow-ups.
Wellbutrin (NDRI) is activating and less likely to cause sexual dysfunction or weight gain. Zoloft (SSRI) is often better for anxiety disorders and has more serotonergic side effects like GI upset and sexual dysfunction. Choice depends on symptom profile and tolerability.
Wellbutrin boosts dopamine/norepinephrine and can aid energy and libido; Prozac is an SSRI with a long half-life, often helpful for depression with comorbid anxiety or OCD. Prozac may cause more sexual side effects and initial GI upset; Wellbutrin may cause insomnia or jitteriness.
Lexapro is an SSRI known for good tolerability and strong anxiety relief. Wellbutrin is preferable when avoiding sexual side effects or sedation, or when targeting low motivation and fatigue. Lexapro may be better for primary anxiety; Wellbutrin for low-energy depression or SSRI augmentation.
Paxil is an SSRI with higher risks of weight gain, sexual dysfunction, and discontinuation symptoms. Wellbutrin tends to be more weight-neutral and activating but can worsen insomnia. Paxil can be effective for anxiety disorders; Wellbutrin may suit those prioritizing energy and sexual function.
Celexa is an SSRI limited by QT prolongation risk at higher doses. Wellbutrin lacks QT concerns at standard doses and has fewer sexual side effects. Celexa may be smoother for anxiety; Wellbutrin may better address fatigue and concentration issues.
Effexor is an SNRI affecting serotonin and, at higher doses, norepinephrine; it’s potent for anxiety and pain syndromes but can raise blood pressure and cause discontinuation symptoms. Wellbutrin has fewer sexual side effects and is stimulating, with seizure risk at high doses or misuse.
Cymbalta (SNRI) treats depression, anxiety, and neuropathic pain or fibromyalgia, but may cause nausea and sweating. Wellbutrin is better for minimizing sexual side effects and promoting energy, but not a first-line agent for generalized anxiety or pain conditions.
Pristiq is an SNRI with once-daily dosing and potential blood pressure elevation and sweating. Wellbutrin may be chosen to avoid sexual side effects or sedation; Pristiq can be favored when anxiety or pain features predominate.
Remeron is sedating, increases appetite and weight, and can help with insomnia and anxiety. Wellbutrin is activating and may promote weight loss or neutrality. The two are sometimes combined to balance sleep, appetite, and energy.
Trintellix is a multimodal serotonergic antidepressant that may benefit cognition and has relatively lower sexual side effects than many SSRIs. Wellbutrin still tends to be better for preserving libido and countering fatigue; Trintellix may be gentler for anxiety.
Viibryd combines SSRI action with partial 5-HT1A agonism and is often used for depression with anxiety, though GI side effects are common initially. Wellbutrin is less likely to cause sexual dysfunction and can boost motivation, but may aggravate insomnia.
Both contain bupropion; SR is typically dosed twice daily, XL once daily. XL offers steadier levels and may reduce peaks linked to side effects like jitteriness or insomnia. Efficacy is similar when total daily dose is equivalent.
As monotherapy, Wellbutrin minimizes sexual side effects and can increase energy. Added to an SSRI, it can offset SSRI-related sexual dysfunction, weight gain, and fatigue while enhancing antidepressant response. Combination increases complexity and monitoring needs.
Generic bupropion contains the same active ingredient and is considered therapeutically equivalent when approved. Some patients notice differences in release profile or side effects among manufacturers; discuss consistent sourcing if you’re sensitive to changes.
They are both bupropion; “Zyban” refers to the sustained-release product labeled for smoking cessation with specific dosing and quit-date guidance. If you’re using bupropion for both depression and quitting smoking, your clinician can tailor one regimen to cover both goals.